Acinetobacter baumannii

Experimental Therapeutics
Combating Multidrug-Resistant Pathogens with Host-Directed Nonantibiotic Therapeutics
Jourdan A. Andersson, Jian Sha, Michelle L. Kirtley, Emily Reyes, Eric C. Fitts, Sara M. Dann, Ashok K. Chopra
Mechanisms of Resistance
Kinetics of Sulbactam Hydrolysis by β-Lactamases, and Kinetics of β-Lactamase Inhibition by Sulbactam
Adam B. Shapiro
Open Access

Experimental Therapeutics
SPR741, an Antibiotic Adjuvant, Potentiates the In Vitro and In Vivo Activity of Rifampin against Clinically Relevant Extensively Drug-Resistant Acinetobacter baumannii
Daniel V. Zurawski, Alexandria A. Reinhart, Yonas A. Alamneh, Michael J. Pucci, Yuanzheng Si, Rania Abu-Taleb, Jonathan P. Shearer, Samandra T. Demons, Stuart D. Tyner, Troy Lister
Mechanisms of Action: Physiological Effects
Potent β-Lactam Enhancer Activity of Zidebactam and WCK 5153 against Acinetobacter baumannii, Including Carbapenemase-Producing Clinical Isolates
Bartolome Moya, Isabel M. Barcelo, Sachin Bhagwat, Mahesh Patel, German Bou, Krisztina M. Papp-Wallace, Robert A. Bonomo, Antonio Oliver
Mechanisms of Resistance
Nosocomial Outbreak of Extensively Drug-Resistant Acinetobacter baumannii Isolates Containing bla_OXA-237 Carried on a Plasmid
Andrea M. Hujer, Paul G. Higgins, Susan D. Rudin, Genevieve L. Buser, Steven H. Marshall, Kyriaki Xanthopoulou, Harald Seifert, Laura J. Rojas, T. Nicholas Domitrovic, P. Maureen Cassidy, Margaret C. Cunningham, Robert Vega, Jon P. Furuno, Christopher D. Pfeiffer, Zintars G. Beldavs, Meredith S. Wright, Michael R. Jacobs, Mark D. Adams, Robert A. Bonomo
Experimental Therapeutics
Activity of the β-Lactamase Inhibitor LN-1-255 against Carbapenem-Hydrolyzing Class D β-Lactamases from Acinetobacter baumannii
Juan Carlos Vázquez-Ucha, María Maneiro, Marta Martínez-Guitián, John Buynak, Christopher R. Bethel, Robert A. Bonomo, Germán Bou, Margarita Poza, Concepción González-Bello, Alejandro Beceiro
Open Access

Experimental Therapeutics
Development and Use of Personalized Bacteriophage-Based Therapeutic Cocktails To Treat a Patient with a Disseminated Resistant Acinetobacter baumannii Infection
Robert T. Schooley, Biswajit Biswas, Jason J. Gill, Adriana Hernandez-Morales, Jacob Lancaster, Lauren Lessor, Jeremy J. Barr, Sharon L. Reed, Forest Rohwer, Sean Benler, Anca M. Segall, Randy Taplitz, Davey M. Smith, Kim Kerr, Monika Kumaraswamy, Victor Nizet, Leo Lin, Melanie D. McCauley, Steffanie A. Strathdee, Constance A. Benson, Robert K. Pope, Brian M. Leroux, Andrew C. Picel, Alfred J. Mateczun, Katherine E. Cilwa, James M. Regeimbal, Luis A. Estrella, David M. Wolfe, Matthew S. Henry, Javier Quinones, Scott Salka, Kimberly A. Bishop-Lilly, Ry Young, Theron Hamilton
Experimental Therapeutics
A Human Biofilm-Disrupting Monoclonal Antibody Potentiates Antibiotic Efficacy in Rodent Models of both Staphylococcus aureus and Acinetobacter baumannii Infections
Yan Q. Xiong, Angeles Estellés, L. Li, W. Abdelhady, R. Gonzales, Arnold S. Bayer, Edgar Tenorio, Anton Leighton, Stefan Ryser, Lawrence M. Kauvar
Letter to the Editor
Contribution of the TetB Efflux Pump to Minocycline Susceptibility among Carbapenem-Resistant Acinetobacter baumannii Strains
Peng Wang, Christi L. McElheny, Roberta T. Mettus, Robert M. Q. Shanks, Yohei Doi
Mechanisms of Action: Physiological Effects
Subinhibitory Concentrations of Trimethoprim and Sulfamethoxazole Prevent Biofilm Formation by Acinetobacter baumannii through Inhibition of Csu Pilus Expression
Ki Hwan Moon, Brent S. Weber, Mario F. Feldman

Main menu

User menu

Search

Acinetobacter baumannii

Pages